Synamics Therapeutics ApS: Financial statements 2025
CVR: 44258048
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Synamics Therapeutics ApS (CVR 44258048) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 129,466 and a net result of DKK -588,453 compared with DKK -1,554,274 the year before. Equity in the 2025 report amounted to DKK -114,946.
- Gross Profit
- DKK 129,466
- Profit/Loss
- DKK -588,453
- Equity
- DKK -114,946
- Total Assets
- DKK 747,680
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 129K | -588K | -115K | - |
| 2024 | - | -1.7M | -1.6M | 473K | - |
Official annual report
How creditworthy is Synamics Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Synamics Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -1,694,760, and the net result was DKK -1,554,274.
As of March 27, 2025, is registered as an owner of Synamics Therapeutics ApS with an ownership share of 100%.
About Synamics Therapeutics ApS
Synamics Therapeutics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Violet Zahedi. The board consists of Aaron Daniel Capar (chair), Albert Jelke Kooistra, Per Falholt and Violet Zahedi. The company is owned by Synamics Therapeutics Inc.. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 129,466 and a net result of DKK -588,453 compared with DKK -1,554,274 the year before. Equity in the 2025 report amounted to DKK -114,946.
